Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 4, 2006, Pages 1470-1479

  Malakhov, Michael P ^a   Aschenbrenner, Laura M ^a   Smee, Donald F ^b   Wandersee, Miles K ^b   Sidwell, Robert W ^b   Gubareva, Larisa V ^c   Mishin, Vasiliy P ^c   Hayden, Frederick G ^c   Kim, Do Hyong ^a   Ing, Alice ^a   Campbell, Erin R ^a   Yu, Mang ^a   Fang, Fang ^a  

^a NexBio Inc   (United States)

^b UTAH STATE UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAS181 PROTEIN; HYBRID PROTEIN; SIALIC ACID; SIALIDASE; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ACTINOMYCES VISCOSUS; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVIAN INFLUENZA; CELL PROTECTION; CELL SURFACE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SAFETY; ENZYME ACTIVE SITE; EPIDEMIC; FEMALE; FERRET; HUMAN; IN VIVO STUDY; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; ANTIVIRAL AGENTS; BACTERIAL ADHESION; CATALYTIC DOMAIN; CELL LINE; DOGS; FEMALE; FERRETS; GLYCOPROTEINS; HUMANS; INFLUENZA, HUMAN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED BALB C; NEURAMINIDASE; ORTHOMYXOVIRIDAE; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; VIRUS REPLICATION;

EID: 33645765519     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.4.1470-1479.2006     Document Type: Article

References (60)

1. Achyuthan, K. E., and A. M. Achyuthan. 2001. Comparative enzymology, biochemistry, and pathophysiology of human exo-α-sialidases (neuraminidases). Comp. Biochem. Physiol. B Biochem. Mol. Biol. 129:29-64.
2. Air, G. M., and W. G. Laver. 1995. Red cells bound to influenza virus N9 neuraminidase are not released by the N9 neuraminidase activity. Virology 211:278-284.
3. Baker, N., G. C. Hansson, H. Leffler, G. Riise, and C. Svanborg-Eden. 1990. Glycosphingolipid receptors for Pseudomonas aeruginosa. Infect. Immun. 58:2361-2366.
4. Barthelson, R., A. Mobasseri, D. Zopf, and P. Simon. 1998. Adherence of Streptococcus pneumoniae to respiratory epithelial cells is inhibited by sialylated oligosaccharides. Infect. Immun. 66:1439-1444.
5. Beigel, J. H., J. Farrar, A. M. Han, F. G. Hayden, R. Hyer, M. D. de Jong, S. Lochindarat, T. K. Nguyen, T. H. Nguyen, T. H. Tran, A. Nicoll, S. Touch, and K. Y. Yuen. 2005. Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 353:1374-1385.
6. Bergelson, L. D., A. G. Bukrinskaya, N. V. Prokazova, G. I. Shaposhnikova, S. L. Kocharov, V. P. Shevchenko, G. V. Kornilaeva, and E. V. Fomina-Ageeva. 1982. Role of gangliosides in reception of influenza virus. Eur. J. Biochem. 128:467-474.
7. Chen, H., G. Deng, Z. Li, G. Tian, Y. Li, P. Jiao, L. Zhang, Z. Liu, R. G. Webster, and K. Yu. 2004. The evolution of H5N1 influenza viruses in ducks in southern China. Proc. Natl. Acad. Sci. USA 101:10452-10457.
8. Drzeniek, R. 1973. Substrate specificity of neuraminidases. Histochem. J. 5:271-290.
9. Els, M. C., W. G. Laver, and G. M. Air. 1989. Sialic acid is cleaved from glycoconjugates at the cell surface when influenza virus neuraminidases are expressed from recombinant vaccinia viruses. Virology 170:346-351.
10. Fakih, M. G., T. F. Murphy, M. A. Pattoli, and C. S. Berenson. 1997. Specific binding of Haemophilus influenzae to minor gangliosides of human respiratory epithelial cells. Infect. Immun. 65:1695-1700.
11. Gaskell, A., S. Crennell, and G. Taylor. 1995. The three domains of a bacterial sialidase: a beta-propeller, an immunoglobulin module and a galactose-binding jelly-roll. Structure 3:1197-1205.
12. Gottschalk, A. 1959. The Viruses. Academic Press, Inc., New York, N. Y.
13. Griffin, J. A., S. Basak, and R. W. Compans. 1983. Effects of hexose starvation and the role of sialic acid in influenza virus release. Virology 125:324-334.
14. Gutierrez, C., M. J. Martin, and K. A. Brown. 1987. Complement activation by human lymphocytes from different lymphoid organs: role of sialic acid and lack of relationship to electrical surface charge. Complement 4:99-109.
15. Hassid, S., G. Choufani, N. Nagy, H. Kaltner, A. Danguy, H. J. Gabius, and R. Kiss. 1999. Quantitative glycohistochemical characterization of normal nasal mucosa, and of single as opposed to massive nasal polyps. Ann. Otol. Rhinol. Laryngol. 108:797-805.
16. Hazlett, L. D., M. Moon, and R. S. Berk. 1986. In vivo identification of sialic acid as the ocular receptor for Pseudomonas aeruginosa. Infect. Immun. 51:687-689.
17. Henrickson, K. J. 2003. Parainfluenza viruses. Clin. Microbiol. Rev. 16:242-264.
18. Hierholzer, J. C., and R. A. Killington. 1996. Virus isolation and quantitation, p. 25-46. In B. W. J. Mahy and H. O. Kangro (ed.), Virology methods manual. Academic Press, Ltd., London, England.
19. Hirsch, R. L., J. S. Wolinsky, and J. A. Winkelstein. 1986. Activation of the alternative complement pathway by mumps infected cells: relationship to viral neuraminidase activity. Arch. Virol. 87:181-190.
20. Ito, T. 2000. Interspecies transmission and receptor recognition of influenza A viruses. Microbiol. Immunol. 44:423-430.
21. Jarreau, P. H., A. Harf, M. Levame, C. R. Lambre, H. Lorino, and I. Macquin-Mavier. 1992. Effects of neuraminidase on airway reactivity in the guinea pig. Am. Rev. Respir. Dis. 145:906-910.
22. Kai, H., K. Makise, S. Matsumoto, T. Ishii, K. Takahama, Y. Isohama, and T. Miyata. 1992. The influence of neuraminidase treatment on tracheal smooth muscle contraction. Eur. J. Pharmacol. 220:181-185.
23. Kannan, S., R. A. Lakku, D. Niranjali, K. Jayakumar. A. H. Steven, V. V. Taralakshmi, S. Chandramohan, R. Balakrishnan, C. Schmidt, and D. Halagowder. 2003. Expression of peanut agglutinin-binding mucin-type glycoprotein in human esophageal squamous cell carcinoma as a marker. Mol. Cancer 2:38.
24. Kawakami, K., K. Ahmed, Y. Utsunomiya, N. Rikitomi, A. Hori, K. Oishi, and T. Nagatake. 1998. Attachment of nontypable Haemophilus influenzae to human pharyngeal epithelial cells mediated by a ganglioside receptor. Microbiol. Immunol. 42:697-702.
25. King, M., A. Gilboa, F. A. Meyer, and A. Silberberg. 1974. On the transport of mucus and its rheologic simulants in ciliated systems. Am. Rev. Respir. Dis. 110:740-745.
26. Kiso, M., Y. Sakai-Tagawa, K. Shiraishi, C. Kawakami, K. Kimura, F. G. Hayden, N. Sugaya, and Y. Kawaoka. 2004. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364:759-765.
27. Le, Q. M., M. Kiso, K. Someya, Y. T. Sakai, T. H. Nguyen, K. H. Nguyen, N. D. Pham, H. H. Ngyen, S. Yamada, Y. Muramoto, T. Horimoto, A. Takada, H. Goto, T. Suzuki, Y. Suzuki, and Y. Kawaoka. 2005. Avian flu: isolation of drug-resistant H5N1 virus. Nature 437:1108.
28. Marcus, H., A. Austria, and N. R. Baker. 1989. Adherence of Pseudomonas aeruginosa to tracheal epithelium. Infect. Immun. 57:1050-1053.
29. Matrosovich, M. N., T. Y. Matrosovich, T. Gray, N. A. Roberts, and H. D. Klenk. 2004. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA 101:4620-4624.
30. McCullers, J. A., and K. C. Bartmess. 2003. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J. Infect. Dis. 187:1000-1009.
31. Mendel, D. B., C. Y. Tai, P. A. Escarpe, W. Li, R. W. Sidwell, J. H. Huffman, C. Sweet, K. J. Jakeman, J. Merson, S. A. Lacy, W. Lew, M. A. Williams, L. Zhang, M. S. Chen, N. Bischofberger, and C. U. Kim. 1998. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection. Antimicrob. Agents Chemother. 42:640-646.
32. Meyer, F. A., M. King, and R. A. Gelman. 1975. On the role of sialic acid in the rheological properties of mucus. Biochim. Biophys. Acta 392:223-232.
33. Michalek, M. T., E. G. Bremer, and C. Mold. 1988. Effect of gangliosides on activation of the alternative pathway of human complement. J. Immunol. 140:1581-1587.
34. Monti, E., A. Preti, C. Nesti, A. Ballabio, and G. Borsani. 1999. Expression of a novel human sialidase encoded by the NEU2 gene. Glycobiology 9:1313-1321.
35. Pangburn, M. K., K. L. Pangburn, V. Koistinen, S. Meri, and A. K. Sharma. 2000. Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement. J. Immunol. 164:4742-4751.
36. Peltola, V. T., and J. A. McCullers. 2004. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr. Infect. Dis. J. 23:S87-S97.
37. Peltola, V. T., K. G. Murti, and J. A. McCullers. 2005. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J. Infect. Dis. 192:249-257.
38. Potier, M., L. Mameli, M. Belisle, L. Dallaire, and S. B. Melancon. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl- α-D-N-acetylneuraminate) substrate. Anal. Biochem. 94:287-296.
39. Ramphal, R., and M. Pyle. 1983. Evidence for mucins and sialic acid as receptors for Pseudomonas aeruginosa in the lower respiratory tract. Infect. Immun. 41:339-344.
40. Ramphal, R., and M. Pyle. 1985. Further characterization of the tracheal receptor for Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. 4:160-162.
41. Reichner, J. S., S. W. Whiteheart, and G. W. Hart. 1988. Intracellular trafficking of cell surface sialoglycoconjugates. J. Biol. Chem. 263:16316-16326.
42. Reuman, P. D., S. Keely, and G. M. Schiff. 1989. Assessment of signs of influenza illness in the ferret model. J. Virol. Methods 24:27-34.
43. Saiman, L., G. Cacalano, D. Gruenert, and A. Prince. 1992. Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects. Infect. Immun. 60:2808-2814.
44. Schauer, R. 1982. Chemistry, metabolism, and biological functions of sialic acids. Adv. Carbohydr. Chem. Biochem. 40:131-234.
45. Seki, M., Y. Higashiyama, K. Tomono, K. Yanagihara, H. Ohno, Y. Kaneko, K. Izumikawa, Y. Miyazaki, Y. Hirakata, Y. Mizuta, T. Tashiro, and S. Kohno. 2004. Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa. Clin. Exp. Immunol. 137:35-40.
46. Shoyab, M., G. D. Plowman, V. L. McDonald, J. G. Bradley, and G. J. Todaro. 1989. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 243:1074-1076.
47. Sidwell, R. W., J. H. Huffman, E. W. Call, H. Alaghamandan, P. D. Cook, and R. K. Robins. 1986. Effect of selenazofurin on influenza A and B virus infections of mice. Antivir. Res. 6:343-353.
48. Sidwell, R. W., J. H. Huffman, J. Gilbert, B. Moscon, G. Pedersen, R. Burger, and R. P. Warren. 1992. Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice. Antimicrob. Agents Chemother. 36:473-476.
49. Sinn, P. L., G. Williams, S. Vongpunsawad, R. Cattaneo, and P. B. McCray, Jr. 2002. Measles virus preferentially transduces the basolateral surface of well-differentiated human airway epithelia. J. Virol. 76:2403-2409.
50. Smee, D. F., J. H. Huffman, A. C. Morrison, D. L. Barnard, and R. W. Sidwell. 2001. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities. Antimicrob. Agents Chemother. 45:743-748.
51. Smith, H., and C. Sweet. 1988. Lessons for human influenza from pathogenicity studies with ferrets. Rev. Infect. Dis. 10:55-75.
52. Stray, S. J., R. D. Cummings, and G. M. Air. 2000. Influenza virus infection of desialylated cells. Glycobiology 10:649-658.
53. Sutter, V. L. 1984. Anaerobes as normal oral flora. Rev. Infect. Dis. 6:S62-S66.
54. Teufel, M., P. Roggentin, and R. Schauer. 1989. Properties of sialidase isolated from Actinomyces viscosus DSM 43798. Biol. Chem. Hoppe-Seyler 370:435-443.
55. van Alphen, L., L. Geelen-van den Broek, L. Blaas, M. van Ham, and J. Dankert. 1991. Blocking of fimbria-mediated adherence of Haemophilus influenzae by sialyl gangliosides. Infect. Immun. 59:4473-4477.
56. Varki, A. 1992. Selectins and other mammalian sialic acid-binding lectins. Curr. Opin. Cell Biol. 4:257-266.
57. Varki, A. 1997. Sialic acids as ligands in recognition phenomena. FASEB J. 11:248-255.
58. Wu, W., and G. M. Air. 2004. Binding of influenza viruses to sialic acids: reassortant viruses with A/NWS/33 hemagglutinin bind to α2,8-linked sialic acid. Virology 325:340-350.
59. Yeung, M. K. 1993. Complete nucleotide sequence of the Actinomyces viscosus T14V sialidase gene: presence of a conserved repeating sequence among strains of Actinomyces spp. Infect. Immun. 61:109-116.
60. Zhang, L., M. E. Peeples, R. C. Boucher, P. L. Collins, and R. J. Pickles. 2002. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J. Virol. 76:5654-5666.